Finn Mohring - Demant AS VP RD

All Insiders . USA . 
Stock . Demant AS ADR . Stakeholders . Insider . Finn Mohring
WILYY Stock  USD 19.37  0.51  2.70%   

Insider

Finn Mohring is VP RD of Demant AS ADR
Phone45 39 17 73 00
Webhttps://www.demant.com

Demant AS Management Efficiency

The company has return on total asset (ROA) of 0.071 % which means that it generated a profit of $0.071 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2752 %, meaning that it generated $0.2752 on every $100 dollars invested by stockholders. Demant AS's management efficiency ratios could be used to measure how well Demant AS manages its routine affairs as well as how well it operates its assets and liabilities.
Demant AS ADR has accumulated 6.1 B in total debt with debt to equity ratio (D/E) of 1.64, which is about average as compared to similar companies. Demant AS ADR has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Demant AS until it has trouble settling it off, either with new capital or with free cash flow. So, Demant AS's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Demant AS ADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Demant to invest in growth at high rates of return. When we think about Demant AS's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Lawrence MertzAccelerate Diagnostics
61
Matthew PigeonInogen Inc
N/A
Mark MDBluejay Diagnostics
N/A
Jeffrey Sirekicad inc
N/A
Jason CookBluejay Diagnostics
42
Lars AndersenLangeGN Store Nord
N/A
Brian PedersenGN Store Nord
N/A
Paul VerrastroCVRx Inc
61
Veronica CaiTivic Health Systems
48
Elisabeth StaudingerSiemens Healthineers AG
53
Birgit ConixSonova Holding AG
58
Khan MDHyperfine
50
Sandra EayrsNuwellis
N/A
Marc KoebernickSiemens Healthineers AG
N/A
Stephen Sarnoicad inc
57
Carsten BertramSiemens Healthineers AG
N/A
Jennifer StevensonCochLear Ltd ADR
N/A
Kristina DevonCochLear Ltd ADR
N/A
Aurangzeb KhanGN Store Nord
N/A
Sanjay AhujaTivic Health Systems
N/A
Neela PaykelHyperfine
53
Demant AS, a hearing healthcare and audio technology company, develops, manufactures, and sells products and equipment to enhance peoples hearing in Europe, North America, the Pacific, Asia, and internationally. Demant AS was founded in 1904 and is headquartered in Smrum, Denmark. Demant As is traded on OTC Exchange in the United States. Demant AS ADR [WILYY] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading.

Management Performance

Return On Equity0.28
Return On Asset0.071

Demant AS ADR Leadership Team

Elected by the shareholders, the Demant AS's board of directors comprises two types of representatives: Demant AS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Demant. The board's role is to monitor Demant AS's management team and ensure that shareholders' interests are well served. Demant AS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Demant AS's outside directors are responsible for providing unbiased perspectives on the board's policies.
Arne MBA, Pres Board
Mathias Mller, Head Relations
Trine KromannMikkelsen, VP Relations
Niels Wagner, Head of Retail
Finn Mohring, VP RD
Sren Nielsen, Pres CEO
Ren MSc, CFO Board

Demant Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Demant AS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.28
Return On Asset0.071
Profit Margin0.11 %
Operating Margin0.16 %
Current Valuation8.18 B
Shares Outstanding446.37 M
Price To Earning36.83 X
Price To Book5.38 X
Price To Sales0.34 X
Revenue19.7 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
TITANTitan Company Limited
UUnity Software
PAYCPaycom Soft

Additional Tools for Demant Pink Sheet Analysis

When running Demant AS's price analysis, check to measure Demant AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Demant AS is operating at the current time. Most of Demant AS's value examination focuses on studying past and present price action to predict the probability of Demant AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Demant AS's price. Additionally, you may evaluate how the addition of Demant AS to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY